Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Study shows lasting benefit of radiotherapy after surgery in prostate cancer

Written by | 14 Dec 2012

by Bruce Sylvester – taken from The Lancet – Radiotherapy given immediately after prostate removal surgery has a long-term benefit of preventing  progression of the disease, researchers reported… read more.

Early resection of low-grade gliomas brings better survival rate than watchful waiting

Written by | 14 Dec 2012

by Bruce Sylvester – taken from the Journal of the American Medical Association (JAMA) – Researchers comparing methods for treating low-grade gliomas have found early surgical resection produced… read more.

Aspirin therapy extends life in colorectal cancer patients with specific gene mutation

Written by | 14 Dec 2012

by Bruce Sylvester – taken from the New England Journal of Medicine (NEJM) – Aspirin therapy appears to extend life in colorectal cancer patients with tumors having a… read more.

Study reveals motivation behind ‘sunbed’ use

Written by | 13 Dec 2012

by Gary Finnegan – World Health Matters (Germany) – Millions of people in Europe, the US and elsewhere use tanning beds every year ignoring the risk of skin… read more.

ASCO 2012 Report – New treatment option for women with platinum resistant ovarian cancer

Written by | 20 Nov 2012

by Marybeth Burke – Adding bevacizumab to chemotherapy halves the risk of the disease getting worse in platinum resistant patients with ovarian cancer,

ASCO 2012 Report – Crizotinib shows promise in patients with advanced NSCLC with ROS1 rearrangements

Written by | 20 Nov 2012

by Marybeth Burke – Crizotinib demonstrated significant anti-tumour activity in patients with advanced non-small cell lung cancer (NSCLC) harbouring ROS1 rearrangements,

ASCO 2012 Report – Radiation in childhood cancer increases risk of breast cancer

Written by | 20 Nov 2012

by Marybeth Burke – Women treated for childhood cancer with chest radiation therapy have a high risk of developing breast cancer at a young age, comparable to that… read more.

ASCO 2012 Report – Regorafenib improves outcomes in patients with GIST

Written by | 20 Nov 2012

by Marybeth Burke – Regorafenib significantly improved progression-free survival (PFS) and disease control rate (DCR) in patients with advanced gastrointestinal stromal tumours (GIST) that progress due to resistance… read more.

ASCO 2012 Report – T-DM1 improves progression free survival in breast cancer

Written by | 20 Nov 2012

by Marybeth Burke – The investigational agent trastuzumab emtansine (T-DM1) demonstrated improved efficacy over capecitibine plus lapatinib and improved progression-free survival (PFS) in women with HER2-positive locally advanced… read more.

ASCO 2012 Report – Trametinib delays tumour growth and extends survival in certain melanoma patients

Written by | 20 Nov 2012

by Marybeth Burke – Median progression-free survival (PFS) was significantly greater in the trametinib group, 4.8 months, vs the chemotherapy group, 1.4 months, according to a study presented

ASCO 2012 Report – American Ginseng alleviates cancer related fatigue

Written by | 20 Nov 2012

by Marybeth Burke – Wisconsin grown ginseng significantly reduced cancer related fatigue in patients receiving cancer treatment after 8 weeks of ginseng treatment,

ASCO 2012 Report – Clear downside to intermittent hormonal therapy in metastatic prostate cancer in certain men

Written by | 20 Nov 2012

by Marybeth Burke – Continuous hormonal therapy is more effective than intermittent hormonal therapy for men with hormone-sensitive metastatic prostate cancer with minimal disease spread,

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.